G. Los et al., COMBINATION TREATMENT OF CISPLATIN AND CARBOPLATIN IN CANCERS RESTRICTED TO THE PERITONEAL-CAVITY IN THE RAT, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 425-433
In the present study, cisplatin (cDDP) and carboplatin (CBDCA) were co
mbined in different in vitro and in vivo assays to determine whether c
ombined cDDP and CBDCA treatment would eventually lead to a better ant
itumor response. Co-incubation of CC531 cells with cDDP and CBDCA led
to higher intracellular Pt concentrations (130.5+/-3.4 ng Pt/10(6) cel
ls) than did cDDP (16.9+/-9.4 ng Pt/10(6) cells) or CBDCA (1.28+/-0.72
ng Pt/10(6) cells) incubation alone. In survival assays an additive c
ell kill was seen after combined treatment with cDDP and CBDCA. DNA bi
nding experiments using isolated salmon-sperm DNA exposed to the drugs
separately or in combination were in agreement with the survival stud
ies (for cDDP a binding of 12.42 mug Pt/mg DNA; for CBDCA, 0.49 mug Pt
/mg DNA; and for combined CBDCA and cDDP, 12.9 mug Pt/mg DNA at 76 h).
Toxicity studies in rats treated with cDDP plus CBDCA required a dose
reduction for cDDP amounting to 20% of the MTD, whereas the CBDCA dos
e could be maintained. Pharmacokinetics studies showed higher AUCs and
t1/2beta in plasma as well as the peritoneal cavity after combined tr
eatment with cDDP and CBDCA (both given i.p.) or following cDDP given
i.p. and CBDCA given i.v. Pt concentrations in peritoneal tumors corre
sponded with these observations, with higher Pt concentrations followi
ng combined treatment than after single-agent injection. In addition,
combined administration of cDDP i.p. and CBDCA i.v. led to higher Pt c
oncentrations in peritoneal tumors than did administration of both dru
gs i.p. (3.93+/-0.9 vs 2.76+/-0.2 mg Pt/g tissue). The higher Pt conce
ntrations in the peritoneal tumors after combined treatment was associ
ated with a significantly better antitumor response in comparison with
that observed after single-agent treatment (a growth delay of 30.2+/-
5.6 days for cDDP i.p. plus CBDCA i. v. vs 16.1+/-5.4 days for cDDP al
one and 10.8+/-4.2 days for CB DCA alone).